newsfilter
← Latest News
PR Newswire·

$170B Patent Cliff Ignites Biotech Deal Wave: Late-Stage Platforms Command Premium

The oncology sector is undergoing a massive capital rotation driven by over 50 FDA approvals in 2025, with 20 arriving in Q4 alone[1]. This...